Fatigue before, during and after antiviral therapy of chronic hepatitis C: Results from the Virahep-C study

Zhen Jiang, Abdus S. Wahed, Donna M. Evon, Jay H. Hoofnagle, Souvik Sarkar
Fatigue is the most frequent and often debilitating symptom of chronic hepatitis C. It is unclear whether successful therapy of hepatitis C leads to its clinical improvement. In the Virahep-C study, patients with hepatitis C virus (HCV) genotype 1 infection were treated with peginterferon alfa-2a and ribavirin for up to 48 weeks while undergoing assessment of viral kinetics and clinical symptoms.
doi:10.17615/1v3f-jn21 fatcat:f345z7r6lfh77a74wlzr2ksbum